The University of Chicago Header Logo

Connection

Jennifer Cooperrider to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Jennifer Cooperrider has written about Treatment Outcome.
Jennifer Cooperrider
Connection Strength
0.022
Treatment Outcome
  1. Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant. Blood Cancer J. 2024 05 29; 14(1):87.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.